Metagenomi Therapeutics (MGX) Trading Update
Metagenomi Therapeutics (ticker: MGX) closed its trading session at USD 0.83 on popular exchanges, reflecting a 3.57 % increase over the previous 24‑hour period ending at 04:06 AM Central Europe on Wednesday, 21 September 2026.
- Current market price: USD 0.83
- Shares outstanding: 37.8 million
- Market capitalization: USD 30.7 million
- Volume traded in last 24 hours: USD 126.5 thousand
- 52‑week high: USD 3.21 (22 October 2025)
- 52‑week low: USD 0.77 (16 October 2026)
- Simple moving average (200 days): USD 1.34
- Month‑to‑month change: -27.5 % decline since the end of the previous month
Recent Performance of Peer Companies
| Ticker | Recent 24‑hour change | Current price | Market cap (USD mn) |
|---|---|---|---|
| BTMD (Biote) | -0.46 % | 1.07 | 36.8 |
| ELWT (Elauwit Connection) | +1.44 % | 5.56 | 36.7 |
| STRR (Star Equity) | +1.12 % | 9.94 | 36.2 |
| SCYX (Scynexis) | -0.27 % | 3.80 | 36.5 |
| PLNH (Planet) | -3.64 % | 0.11 | 35.6 |
Company Background
Metagenomi Inc. is a U.S.-based biotechnology firm that will go public on February 8 2024 through an IPO on the Nasdaq stock exchange.
